M.P.M.H. Rutten-van Mölken (Maureen) , N.H. Chavannes (Nicolas)
Erasmus University Rotterdam
The RECODE trial was funded by Stichting Achmea Gezondheidszorg (SAG) and the Netherlands Organisation for Health Research and Development (ZonMW). The supplementary funding for providing a COPD specific exercise training for the RECODE study was provided by two local Dutch healthcare insurers ‘Centraal Ziekenfonds (CZ) Zorgverzekeringen’ and ‘Zorg en Zekerheid.’ The mapping study (chapter 9) was funded by Boehringer Ingelheim.
Erasmus MC: University Medical Center Rotterdam

Boland, M. (2015, November 12). Cost-effectiveness of disease management programs in COPD. Retrieved from http://hdl.handle.net/1765/79692